Related Experiment Videos
[The value of late thrombolytic perfusion in acute myocardial infarct]
1Klinikum Rudolf Virchow, Franz-Volhard-Klinik und Max-Delbrück-Centrum für Molekulare Medizin, Berlin-Buch.
Insights
The LATE study shows reperfusion therapy for acute myocardial infarction can be extended to 12 hours. This late reperfusion benefits myocardial remodeling and rhythm stabilization, expanding treatment options.
Area of Science:
- Cardiology and Cardiovascular Research
- Thrombolytic Therapy
- Myocardial Infarction Management
Context:
- Traditional views restricted reperfusion therapy for acute myocardial infarction (AMI) to 4-6 hours.
- The LATE study results challenge this established timeframe.
- Recent findings necessitate an expansion of the therapeutic window for AMI interventions.
Purpose:
- To evaluate the efficacy and implications of extending reperfusion therapy for acute myocardial infarction beyond the conventional 6-hour window.
- To investigate the benefits of late reperfusion, focusing on myocardial remodeling and rhythmic stabilization.
- To reconcile early reperfusion goals (myocardial salvage) with potential late reperfusion benefits.
Summary:
- The paradigm for thrombolysis in acute myocardial infarction (AMI) should be expanded to 12 hours, based on the LATE study.
- Early thrombolysis (up to 90 minutes) focuses on myocardial salvage.
- Late reperfusion (beyond 6 hours) appears to improve myocardial remodeling and provide rhythmic stabilization, supporting the 'open artery hypothesis'.
Impact:
- The clinical value of late reperfusion therapy in acute myocardial infarction is now considered proven.
- Further research is needed to fully elucidate the underlying mechanisms of late reperfusion.
- Expanded treatment windows may improve outcomes for patients with acute myocardial infarction.
Abstract:
Contradicting previous views that reperfusion therapy in acute myocardial infarction has to be restricted to the first 4 to 6 h, the paradigm of thrombolysis in acute myocardial infarction has to be expanded to 12 h, since the results of the LATE study have been published. While early thrombolysis (up to 90 min) aims towards myocardial salvage, the benefit of late reperfusion seems to depend on an improved myocardial remodeling and on rhythmic stabilization (open artery hypothesis). Today the value of late reperfusion therapy can be regarded as proven in a clinical setting, the mechanisms of late reperfusion therapy, however, still remain to be settled.